Zura Bio announces CEO resignation and appointment of Sandeep Kulkarni as new CEO

Zura Bio Ltd

Robert Lisicki resigned as CEO and director effective January 21, 2026, after medical leave since October 2025.
Dr. Sandeep Kulkarni appointed CEO and continues as director; will receive $655,000 base salary and equity awards.
Separation agreement with Lisicki includes $72,000 annualized transition compensation through March 31, 2026.
Parvinder Thiara appointed to board effective January 23, 2026; previously served from 2022 to 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.